Clinical Trials Directory

Trials / Completed

CompletedNCT06962826

A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food

Relative Bioavailability of Empagliflozin Tablets After Different Administration Modi in Healthy Male and Female Subjects (Randomised, Two-period Crossover Study)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This trial is conducted to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food.

Conditions

Interventions

TypeNameDescription
DRUGEmpagliflozinEmpagliflozin

Timeline

Start date
2025-05-27
Primary completion
2025-06-26
Completion
2025-09-12
First posted
2025-05-08
Last updated
2025-09-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06962826. Inclusion in this directory is not an endorsement.

A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in (NCT06962826) · Clinical Trials Directory